Evidence map›Paper›PMID 29436405›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2018

Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives.

Panagiotis Paliogiannis, Alessandro G Fois, Salvatore Sotgia, Arduino A Mangoni, Elisabetta Zinellu, Pietro Pirina, Silvia Negri, Ciriaco Carru, Angelo Zinellu

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04923360 (Morphological Parameters of Blood Cell's Activation in Characterization and Prognosis in a COPD Patients Cohort), which is not on this map. Cited by 113 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 6 pooled it
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04923360 unknown statusnot on this map

Morphological Parameters of Blood Cell's Activation in Characterization and Prognosis in a COPD Patients Cohort

Typeobservational_patient_registrySponsorHospital Galdakao-UsansoloRan2018 to 2022Enrolled500ConditionsCOPD
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 6 syntheses or guidelines pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Observational
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Panagiotis PaliogiannisDept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Alessandro G FoisDept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy fois.ale@libero.it.
Salvatore SotgiaDept of Biomedical Sciences, University of Sassari, Sassari, Italy.
Arduino A MangoniDept of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
Elisabetta ZinelluDept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Pietro PirinaDept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Silvia NegriDept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Ciriaco CarruDept of Biomedical Sciences, University of Sassari, Sassari, Italy.
Angelo ZinelluDept of Biomedical Sciences, University of Sassari, Sassari, Italy.
University of Sassari · ITFlinders University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a common cause of hospitalisation and death among COPD patients. Several biochemical markers have been studied as outcome predictors in COPD; however, their measurement often requires significant time and resources. Relatively simple biomarkers of inflammation calculated from routine complete blood count tests, such as the neutrophil to lymphocyte ratio (NLR), might also predict COPD progression and outcomes. This review discusses the available evidence from studies investigating the associations between the NLR, COPD exacerbations and death in this patient group.

Indexed as

LymphocytesNeutrophilsComorbidityDiffusion of InnovationDisease ProgressionEvidence-Based MedicineForecastingHealth StatusHumansLymphocyte CountPredictive Value of TestsPulmonary Disease, Chronic ObstructivePulmonary MedicineRespiratory Tract InfectionsRisk FactorsTreatment Outcome

Identifiers

PMID29436405
PMCPMC9488932
OpenAlexW2786846366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.